This federal contract award to Amerisourcebergen Drug Corp is for the delivery of the pharmaceutical product Bydureon BCISE 2 MG Autoinjector 0.85ML. The contract, valued at $4,614.39, was awarded by the Defense Logistics Agency (DLA) under a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 20, 2024.
Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Generated 2/27/25, 11:41 AM